Study of the Follow-up of Stroke Treated With Anticoagulants "AOD"

Recruiting

Phase N/A Results N/A

Summary of Purpose

Stroke is a major public health problem as it is very frequent (140,000 cases/year in France), and very serious (leading cause of death, 2nd leading cause of dementia, 3rd leading cause of handicap). Ischemic cardio-embolic stroke accounts for around 25% of ischemic strokes, and ischemic cardio-embolic stroke in a context of cardiac arrhythmia due to atrial fibrillation (CAAF) is the leading non-atheromatous...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 September 2017.

1 Jan 2016 21 Sep 2017 1 Dec 2018 1 Dec 2018 1 Sep 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

Not available

Contacts